NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









LENZ Therapeutics

LENZ Therapeutics

Public
Solana Beach, CaliforniaHealthcarewww.lenz-tx.com

Last Round

PIPE

Jul 15, 2024

Total Funding Raised

$214M

Company Overview

LENZ Therapeutics (NAS: LENZ) is a biopharmaceutical company dedicated to developing and commercializing innovative therapies aimed at enhancing vision, with a primary focus on treating presbyopia, a common age-related decline in near vision affecting individuals over 45.

Sector

Healthcare

AI Layer

Non-AI

Keywords

aceclidine-based eye drop for presbyopiaVIZZ (aceclidine ophthalmic solution)FDA-approved presbyopia treatmentonce-daily presbyopia eye droptreatment for age-related blurry near visionpupil-selective mioticpinhole effect eye dropnon-invasive reading glasses alternativepreservative-free ophthalmic solutionophthalmic drug commercializationinternational pharmaceutical licensing

LENZ Therapeutics Comps

Public and private peers based on sector, stage, and business model.

LENZ Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

LENZ Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
PIPEJul 15, 2024
PIPEMar 21, 2024
Series BMar 7, 2023
Series AJun 17, 2021

LENZ Therapeutics Investors

Notable investors and investment history

LENZ Therapeutics investors
InvestorRounds
RA Capital ManagementSeries A, Series B, PIPE
Ridgeback CapitalPIPE
Versant VenturesSeries A, Series B, PIPE
SectoralSeries B
RTW InvestmentsPIPE, Series B
Samsara BioCapitalPIPE
Alpha Wave GlobalSeries B, PIPE

LENZ Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LENZ Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSolana Beach, California
Employee Range160
Year Founded2021
Last FundingJul 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.